Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

log into MY ENETS

ENETS Abstract Search

#457 Comparison of Transarterial Liver-Directed Therapies (LDT) for Low-Grade Metastatic Neuroendocrine Tumors (mNETs)

Introduction: Transarterial LDT can ameliorate symptoms and improve time to tumor progression (TTP) in mNETs.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Engelman E, Leon-Ferre R, Naraev B, Sharma N, Sun S,

Keywords: hepatic, artery, embolization, chemoembolization, radioembolization, neuroendocrine, tumors,

#439 Chromogranin A (CgA) and Pancreastatin (PcSt) as Predictors of Peptide Receptor Radionuclide Therapy (PRRT) Outcomes in Patients with Metastatic Well-Differentiated Neuroendocrine Tumors (mNETs)

Introduction: CgA and PcSt are widely used in assessing response to treatment in mNETs.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Sharma N, Naraev B, Engelman E, Zimmerman M, Bushnell D,

Keywords: pancreastatin, chromogranin, peptide, receptor, radionuclide, therapy, PRRT, neuroendocrine, tumors,

#395 Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) in North American Cohort of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors (mNETs)

Introduction: PRRT is an accepted treatment in Europe for patients (pts) with mNETs, but considered investigational in the USA.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Naraev B, Sharma N, Engelman E, Bushnell D, O'Dorisio T,

Keywords: peptide, receptor, radionuclide, therapy, PRRT, neuroendocrine, tumors,